MING Jian, ZHANG Qingfu, JIANG Yanduo, QIU Xueshan, BAI Xiaozhong
No.202 Hospital of People Liberation Army of China, 110003 Shenyang, China.
Zhongguo Fei Ai Za Zhi. 2010 Dec;13(12):1101-6. doi: 10.3779/j.issn.1009-3419.2010.12.04.
it has been proven that lymph node metastasis was closely related to prognosis of lung cancer. Interleukin-7 (IL-7) and interleukin-7 receptor (IL-7R) could promote lymph node metastasis through vascular endothelial growth factor-D (VEGF-D). The aim of this study is to explore the expressions of IL-7 and IL-7R in lung cancer and the relationship between them with lymph node metastasis and prognosis in non-small cell lung cancer (NSCLC).
the expressions of IL-7 and IL-7R in 95 cases of NSCLC were detected with immunohistochemistry method and the relationship between IL-7 and IL-7R and their impact on lung cancer patients' outcomes were analyzed.
in 95 cases of NSCLC, the high expression rates of IL-7, IL-7R and VEGF-D were 63.16%, 61.05% and 58.95%. The expressions of IL-7 and IL-7R were correlated closely with clinic stage and lymph node metastasis, but had no relationship with age, gender, histological type and differentiation degree. The lymphatic vessel density (LVD) mean of the group with high expressions of IL-7 and IL-7R was higher than that with low or negative expressions of IL-7 and IL-7R, and they were significant different in statistics. Log-rank analysis showed that the postoperative survival period was significantly shorter in high expression groups IL-7, IL-7R and VEGF-D comparing with that in low or negative groups.
the high expression of IL-7 and IL-7R is highly positie correlated with clinic stage, lymph node metastasis, VEGF-D, LVD and poor prognosis in Non-small cell lung cancer.
已证实淋巴结转移与肺癌预后密切相关。白细胞介素-7(IL-7)和白细胞介素-7受体(IL-7R)可通过血管内皮生长因子-D(VEGF-D)促进淋巴结转移。本研究旨在探讨IL-7和IL-7R在肺癌中的表达及其与非小细胞肺癌(NSCLC)淋巴结转移和预后的关系。
采用免疫组织化学方法检测95例NSCLC患者中IL-7和IL-7R的表达,并分析IL-7和IL-7R之间的关系及其对肺癌患者预后的影响。
95例NSCLC患者中,IL-7、IL-7R和VEGF-D的高表达率分别为63.16%、61.05%和58.95%。IL-7和IL-7R的表达与临床分期和淋巴结转移密切相关,但与年龄、性别、组织学类型和分化程度无关。IL-7和IL-7R高表达组的淋巴管密度(LVD)平均值高于IL-7和IL-7R低表达或阴性表达组,差异有统计学意义。Log-rank分析显示,IL-7、IL-7R和VEGF-D高表达组的术后生存期明显短于低表达或阴性组。
IL-7和IL-7R的高表达与非小细胞肺癌的临床分期、淋巴结转移、VEGF-D、LVD及预后不良高度正相关。